Oppenheimer & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503K | Buy |
9,147
+3,736
| +69% | +$205K | 0.01% | 1149 |
|
|
2025
Q1 | $383K | Buy |
+5,411
| New | +$383K | 0.01% | 1175 |
|
|
2024
Q2 | – | Sell |
-4,714
| Closed | -$412K | – | 1441 |
|
|
2024
Q1 | $412K | Buy |
4,714
+1,949
| +70% | +$170K | 0.01% | 1063 |
|
|
2023
Q4 | $267K | Buy |
2,765
+71
| +3% | +$6.85K | ﹤0.01% | 1188 |
|
|
2023
Q3 | $238K | Sell |
2,694
-602
| -18% | -$53.3K | ﹤0.01% | 1211 |
|
|
2023
Q2 | $286K | Buy |
3,296
+369
| +13% | +$32K | 0.01% | 1174 |
|
|
2023
Q1 | $285K | Buy |
+2,927
| New | +$285K | 0.01% | 1140 |
|
|
2015
Q3 | – | Sell |
-11,831
| Closed | -$1.62M | – | 1361 |
|
|
2015
Q2 | $1.62M | Buy |
+11,831
| New | +$1.62M | 0.05% | 475 |
|
|
2014
Q2 | – | Sell |
-3,214
| Closed | -$219K | – | 1415 |
|
|
2014
Q1 | $219K | Sell |
3,214
-2
| -0.1% | -$136 | 0.01% | 1193 |
|
|
2013
Q4 | $226K | Buy |
+3,216
| New | +$226K | 0.01% | 1152 |
|